Guanfacine Extended-release Tablet, Extended Release
Product Images NDC 70518-4266

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Guanfacine Extended-release (NDC 70518-4266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This is a list of different CYP3A4 inhibitors and inducers along with data sources such as human data and computer simulations for evaluating their effects on the PK (pharmacokinetics) of various drugs like oral Methylphenidate and Lisdexamfetamine Dimesylate. The text also mentions fold change and 90% confidence intervals for the AUC (area under the curve) values indicating changes relative to a reference.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure4.jpg (Figure4)

Figure4.jpg (Figure4)
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This text contains information about a medication called Guanfacine extended-release 2mg tablet. The tablet should not be crushed, chewed, or broken before swallowing and should be protected from moisture. The medication should be stored between 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F) as per USP guidelines. The prescription is only for use according to the directions provided in the package insert. It is essential to keep this medication and all others out of the reach of children.*
FDA Label Image

Mm2 (Guanfacine 2mg 70518 4266 01)

Mm2 (Guanfacine 2mg 70518 4266 01)
This text provides information about a 2mg extended-release guanFACINE tablet. The tablet should not be crushed, chewed, or broken before swallowing. It needs to be protected from moisture and kept out of reach of children. The directions for use can be found in the package insert. The tablet should be stored at 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F) according to USP standards. The tablet is manufactured by Apotex Corp and has an NDC#: 70518-4266-01. The repackaging information is provided by RemedyRepack Inc. in Indiana, PA.*
FDA Label Image

Spd503-chemical-stucture (Spd503 Chemical Stucture)

Spd503-chemical-stucture (Spd503 Chemical Stucture)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.